Related Experiment Videos
Solid lipid nanoparticles as drug carriers for topical glucocorticoids
C S Maia1, W Mehnert, M Schäfer-Korting
1Department of Pharmacology and Toxicology, Freie Universität Berlin, D-14195, Berlin, Germany.
International Journal of Pharmaceutics
|March 4, 2000
Summary
Solid lipid nanoparticles (SLN) enhance prednicarbate (PC) skin absorption. This formulation improves drug delivery to the epidermis, offering a safer and more effective topical corticosteroid option.
Area of Science:
- Dermatology
- Nanotechnology
- Pharmacology
Background:
- Prednicarbate (PC) offers a superior benefit/risk ratio compared to halogenated topical glucocorticoids.
- Enhanced drug targeting to the viable epidermis is desired for improved topical corticosteroid efficacy.
- Solid lipid nanoparticles (SLN) present a potential delivery system for improved topical drug absorption.
Purpose of the Study:
- To incorporate prednicarbate (PC) into solid lipid nanoparticles (SLN) for enhanced epidermal targeting.
- To evaluate the toxicity and skin absorption of PC-loaded SLN.
- To compare the efficacy of PC-SLN with conventional PC cream for topical drug delivery.
Main Methods:
- In vitro studies using keratinocyte and fibroblast monolayer cultures.
- Evaluation of reconstructed epidermis and excised human skin.
- Assessment of cellular viability and drug penetration/permeation.
Main Results:
- SLN preparations demonstrated good tolerability, with high cellular viability (94.5%) in reconstructed epidermis after 18 hours.
- PC penetration into human skin increased by 30% compared to PC cream.
- Permeation of PC through reconstructed epidermis increased threefold.
Conclusions:
- Solid lipid nanoparticles (SLN) are a promising system for improving topical drug absorption.
- PC-loaded SLN enhance drug delivery to the skin, potentially increasing therapeutic efficacy.
- This approach offers a viable strategy for developing more effective topical corticosteroid treatments.